STIM Neuronetics
- 2.520
- +0.090+3.70%
- 2.520
- 0.0000.00%
Neuronetics News
Express News | Neuronetics Announced That Humana Has Become The First Commercial Payer To Address TMS Therapy Coverage For Adolescents
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who
Neuronetics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 — William Blair Upgrades Market Perform → Outperform 03/06/2024 207.69% Piper Sandler $7 → $8
Express News | Neuronetics Inc : William Blair Raises to Outperform Rating
Strong Buy Rating for Neuronetics Backed by Solid Financials and Growth Prospects
Take Care Before Jumping Onto Neuronetics, Inc. (NASDAQ:STIM) Even Though It's 36% Cheaper
Neuronetics, Inc. (NASDAQ:STIM) shareholders won't be pleased to see that the share price has had a very rough month, dropping 36% and undoing the prior period's positive performance. The recent dr
Buy Rating on Neuronetics: Solid Fundamentals and Growth Despite Challenges
Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript
Thank you for standing by. Welcome to the Neuronetics First Quarter 2024 Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference call is being recorded.
Neuronetics | 10-Q: Quarterly report
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday's session following weaker-than-expected quarterly results.Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of
PEGY, MTC and IMTE Among Mid-day Movers
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today. Biov
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 75 points on Tuesday.The Dow traded up 0.20% to 38,928.11 while the NASDAQ rose 0.24% to 16,388.57. The S&P 50
Express News | Neuronetics Shares Are Trading Lower After the Company Reported Q1 Financial Results and Issued Q2 Revenue Guidance Below Estimates
Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses
Earnings Flash (STIM) NEURONETICS Reports Q1 Revenue $17.4M
07:43 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (STIM) NEURONETICS Reports Q1 Revenue $17.4M
Neuronetics Inc Releases New Investor Presentation for May 2024
Express News | Neuronetics Expects Q2 Total Worldwide Revenue Between $18.0M-$19.0M Vs. $19.47M Estimate, Company Sees FY24 Revenue Between $78M-$80.0M Vs. $79.13M Estimate
Express News | Neuronetics Inc - Qtrly Shr Loss $0.27
Neuronetics Q1 EPS $(0.27) Beats $(0.34) Estimate, Sales $17.42M Beat $17.12M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.31) by 12.9 percent. This is a 28.95 percent increase over losses of $(0.38) p
Analysis
Price Target
No Data
